Black Diamond Therapeutics
BDTX1.7601.73% ( +0.030 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Black Diamond Therapeutics(BDTX) predict that the EBIT is -11.26 M (-120.7%), Beat estimate;the EPS is -0.16 (-116.3%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B100.00%
----
EBITExceed expectations
-0.01B120.65%
-0.01B120.88%
+0.00B0.23%
EPSExceed expectations
-0.16116.33%
-0.1844118.82%
+0.02442.49%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf